Target intelligence / Profile preview

MT-ND6 pseudogene 21 (MTND6P21)

Target
MTND6P21
Molecular classification
Pseudogene, Other
01

Overview

MT-ND6 pseudogene 21 (MTND6P21) is a nuclear-encoded pseudogene related to the mitochondrial ND6 gene, which normally codes for the ND6 subunit of complex I in the mitochondrial respiratory chain. Unlike the protein-coding ND6 gene—which plays a vital role in mitochondrial energy metabolism and is implicated in diseases such as Leber hereditary optic neuropathy and Leigh syndrome[1][2][5]—MTND6P21 is a non-coding pseudogene, and evidence for its functional biological role or association with human disease is highly limited. Some studies suggest possible expression changes in mitochondrial pseudogenes and isoforms in neurodegenerative diseases, but these links remain unconfirmed and preliminary[4]. There are no known drugs, mechanisms, biomarkers, or safety concerns directly related to MTND6P21. *Note: If a functional target related to the ND6 subunit is required, refer to the canonical mitochondrial ND6 gene (MT-ND6), not MT-ND6 pseudogene 21.*

Other names
MTND6 pseudogene 21mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 pseudogene 21MTND6P21
02

Biological functions

Other (pseudogenes generally lack protein-coding function; limited evidence for regulatory or biomarker roles in this specific case)
03

Disease associations

Other (currently, there is no established direct disease association for MTND6P21; studies of mitochondrial pseudogenes/isoforms—such as related ND1, ND2, ND4, ND5, ND6 pseudogenes—are preliminary and mostly exploratory. Some mitochondrial pseudogenes/isoforms may have altered expression in neurodegenerative disease contexts, but not MTND6P21 specifically)

Beyond the preview

Go deeper on MT-ND6 pseudogene 21 (MTND6P21).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MT-ND6 pseudogene 21 (MTND6P21).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call